StonvexLoading…
StonvexStonvexStonvexCore line items from SSII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Q2 2023 2023-06-30 | Annual 2022 2022-12-31 |
|---|---|---|---|
Revenue | $5.88M | $2.26M | $1.44M |
Operating Income | $-20.27M | $-6.26M | $-2.96M |
Net Income | $-20.88M | $-6.84M | $-3.21M |
EPS (Diluted) | $-0.14 | $-0.05 | $-0.03 |
Total Assets | $31.52M | $12.43M | $6.98M |
Total Liabilities | $11.80M | $11.31M | $9.66M |
Cash & Equivalents | $2.02M | $526.94K | $217.18K |
Free Cash Flow OCF − CapEx | $-15.81M | $-5.48M | $-6.21M |
Shares Outstanding | 170.71M | 146.17M | 128.16M |